All Cases

Biopharma

Strategic positioning of a Parkinson’s Disease therapy being launched in US and EU

Commercial root cause analysis and revised, enhanced commercial strategy for a Parkinson’s Disease treatment

Characterized and segmented the treatment ecosystem for relapsing multiple sclerosis (MS) to inform patient- and ecosystem-support strategies and promote a robust launch for a small biotech

Developed a launch excellence plan, based on local market inputs for a global pharmaceutical company

Developed a comprehensive understanding of referral flows for a Cell Therapy in development for Type 1 Diabetes to inform strategic commercial engagement planning at a mid-sized pharmaceutical company

Defined the key requirements for novel GTx entry and regional access to inform regional access strategies and planned activities and further organizational alignment initiatives

Developed drivers and potential barriers of Hematologist GTx adoption to understand the impacts on patient adoption and inform strategic commercialization planning for a mid-sized biotech

Reconstructed launch experience to inform early commercial planning at a large pharmaceutical company developing a GTx

Characterized Hemophilia GTx Infusion center networks and developed processes to track and validate center readiness, informing commercial strategy and planning at a large pharmaceutical company

Developed a comprehensive understanding of the DMD GTx infrastructure of care to wholistically inform commercial planning for a large pharmaceutical company